>_ QFI Terminal
TerminalStocks › JYNT

The Joint Corp. (JYNT) Stock

Healthcare · Medical - Care Facilities · US
$8.44 +0.12%
Last updated Sep 20, 2026 14:59 UTC

JYNT Key Statistics

Market Cap$120.32M
P/E (TTM)31.26
P/S (TTM)2.05
P/B (TTM)7.57
Revenue (TTM)$58.55M
EPS (TTM)$0.27
Dividend Yield
ROE (TTM)22.00%
Net Margin6.49%
Gross Margin81.08%
52W High$10.58
52W Low$7.50
Analyst ViewBuy
Price Target$20.00
Employees330
Volume382,347

About The Joint Corp.

The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.

CEO: Sanjiv Razdan. Company website

JYNT — Frequently Asked Questions

What is the JYNT stock price today?

The Joint Corp. (JYNT) trades at $8.44, up 0.12% on the day, as of Sep 20, 2026 14:59 UTC.

What is The Joint Corp.'s market cap?

The Joint Corp. has a market capitalisation of $120.32M, calculated from the live JYNT share price and shares outstanding.

What is the P/E ratio of JYNT?

JYNT trades at a trailing P/E of 31.26, from earnings per share of $0.27 over the last twelve months.

How much revenue does The Joint Corp. make?

The Joint Corp. generated revenue of $58.55M over the trailing twelve months, which puts the stock at 2.05 times sales.

What is the 52-week range for JYNT?

JYNT has traded between $7.50 and $10.58 over the past 52 weeks, and the last price is 20.2% below that high.

Is The Joint Corp. profitable?

Yes. The Joint Corp. keeps 6.49% of revenue as net income over the trailing twelve months.

What is the analyst price target for JYNT?

Wall Street analysts rate JYNT Buy, with an average price target of $20.00, 137.0% above the current price.

What sector is The Joint Corp. in?

The Joint Corp. is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.

Who is the CEO of The Joint Corp.?

Sanjiv Razdan is the chief executive of The Joint Corp., which employs 330 people.

Where can I track JYNT in real time?

QFI Terminal shows JYNT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See JYNT live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open JYNT in Terminal See plans

Medical - Care Facilities stocks

HCA HCA Healthcare, Inc. CYH Community Health Systems, Inc. THC Tenet Healthcare Corporation FMS Fresenius Medical Care AG & Co. KGaA UHS Universal Health Services, Inc. DVA DaVita Inc. EHC Encompass Health Corporation SEM Select Medical Holdings Corporation

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.